Bölümler
-
A recent Special Communication published in JAMA points out that the FDA has already approved nearly 1000 devices using AI. Author Robert M. Califf, MD, commissioner of the US Food and Drug Administration, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss AI regulation.
FDA Commissioner Robert Califf on Setting Guardrails for AI in Health Care JAMA AI Interview With Robert M. Califf, MD FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
Related Content: -
A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it's also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in managing decision-making in cardiac care.
AI Can’t Worry About Patients, and a Clinical Ethicist Says That Matters Echoes of Concern—AI and Moral Agency in Medicine
Related Content: -
Widespread adoption of AI raises questions about accountability, transparency, and reproducibility. Marcia McNutt, PhD, president of the National Academy of Sciences, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss advancing scientific knowledge in the age of AI.
National Academies President on How to Use Generative AI Responsibly in Scientific Research
Related Content: -
Researchers Are Exploring the Role of Shingles—and a Protective Role of Shingles Vaccine—in Dementia; Could the Body Roundness Index One Day Replace BMI?
Researchers Are Exploring the Role of Shingles—and a Protective Role of Shingles Vaccine—in Dementia Could the Body Roundness Index One Day Replace the BMI?
Related Content: -
Getting genuinely useful new technologies, from wearables to clinical decision support, into the clinic has proven to be surprisingly challenging. Tanzeem K. Choudhury, PhD, of Cornell Tech joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss how to take research into the real world in a way that is scalable and affordable.
How Health and Technology Sectors Can Collaborate on Better AI-Assisted Wearables
Related Content: -
What hard lessons did the US Department of Veterans Affairs (VA) learn in 3 decades of EHR development, and what can it teach us about building better AI in medicine? Stephen Fihn, MD, MPH, of the University of Washington, and formerly a leader in the VA’s EHR efforts, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss his experience at the VA building decision support tools and other technology.
The VA Was an Early Adopter of Artificial Intelligence to Improve Care—Here’s What They Learned Hello, World—Introducing JAMA+ AI
Related Content: -
European Society of Cardiology Vice President Carlos Aguiar, MD, discusses clinical research highlights from the largest scientific meeting in cardiovascular medicine, held recently in London. Updates include semaglutide findings, hypertension triple pills, and more.
Semaglutide Updates, Hypertension Triple Pills, and More—Heart Health Highlights From ESC Congress
Related Content: -
Related Content:
The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19 -
Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, are the recipients of the 2024 Lasker-Bloomberg Public Service Award for their decades of work on AIDS in Africa. The infectious diseases epidemiologists recently reflected on their life’s work in a conversation with JAMA Deputy Editor and infectious diseases physician Preeti Malani, MD, MSJ.
Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award AIDS in Africa—Impact of Research
Related Content: -
Extreme heat and its health outcomes are becoming more common. Jeremy Hess, MD, MPH, an emergency medicine physician and professor at the University of Washington, and Andrew Phelps, former director of the Oregon Department of Emergency Management, join Jennifer Abbasi, director of JAMA Medical News, to discuss lessons learned from the unprecedented heat wave in June 2021.
As Extreme Heat Becomes More Common, the Unprecedented Pacific Northwest Heat Dome Offers Lessons
Related Content: -
Here’s What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes
As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here’s What to Know Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth
Related Content: -
Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, cochairs of the 2024 Alzheimer’s Association International Conference, speak with JAMA Medical News Lead Senior Staff Writer Rita Rubin, MA, about highlights from the annual meeting, including a blood test for Alzheimer disease, repurposing of a GLP-1 receptor agonist, and the possible brain risk from inhaling wildfire smoke.
A Blood Test for Alzheimer Disease, Repurposing GLP-1s, and Wildfire Smoke—Highlights From the AAIC
Related Content: -
Social media is the focus of the US surgeon general's conversation with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. She interviews Vivek H. Murthy, MD, MBA, to discuss the dangers of social media on youth mental health, highlighting its contribution to the epidemic of loneliness. This is part 2 of a 2-part Q&A.
US Surgeon General Vivek Murthy: To Protect Adolescents, Social Media Needs Warning Labels Social Media Needs Warning Labels: Q&A With Surgeon General Vivek H. Murthy, MD, MBA US Surgeon General Vivek Murthy: Firearm Violence Is a Public Health Crisis Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
Related Content: -
Endocrinologist Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, “game-changing” diabetes technologies, and a new use for a familiar drug.
New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions
Related Content: -
Which Variant Will Updated COVID-19 Vaccines Target This Fall? COVID-19 May Protect Against the Common Cold
Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky COVID-19 May Protect Against the Common Cold—Here’s Why Knowing That Could Lead to Better Vaccines
Related Content: -
This is a 2-part Q&A series with the US Surgeon General. In part 1, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Vivek H. Murthy, MD, MBA, to discuss the issue of gun violence as a pressing public health crisis and the critical role of public health leadership in combating this issue.
US Surgeon General Vivek Murthy: Firearm Violence Is a Public Health Crisis Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
Related Content: -
Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor, and guests share JAMA Network highlights from the American Society of Clinical Oncology’s annual meeting, including new research on colorectal cancer screening, an antibody therapy for non–small cell lung cancer, access to oncology clinical trials, and a new model of palliative care for patients with cancer.
Refining Colon Cancer Screening, Antibody Therapy for Lung Cancer, and More—Highlights From ASCO 2024
Related Content: -
Can data from wearable devices and electronic health records enhance quality improvement in health care? In this Q&A, Sachin Kheterpal, MD, MBA, the University of Michigan Medical School Associate Dean for Research Information Technology, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the potential of data from mobile devices to revolutionize patient care.
Tapping AI’s Strengths—From Operating Room Safety to Wearable Device Interpretation
Related Content: -
Daniel Gibbs, MD, received an Alzheimer disease diagnosis 8 years ago, and in hindsight, believes the earliest symptoms appeared years before that. In this podcast, the retired neurologist speaks with JAMA Medical News lead senior staff writer Rita Rubin, MA, about how even with the neurodegenerative condition, it’s still possible to enjoy a life well-lived.
Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease A Neurologist Learned He Had Alzheimer Disease 8 Years Ago—Here’s What He Wants People to Know
Related Content: -
Multiple Factors Have Contributed to the Comeback of Syphilis in the US; How Statin Eligibility Could Change With the New CVD Risk Calculator
Syphilis Has Surged for Reasons That Go Beyond the Pathogen That Causes It New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions
Related Content: - Daha fazla göster
